IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives

Cited by (221)

Items 101–200 of 221

1. Straight to the Point—The Novel Strategies to Cure Pediatric AML
   Monika Lejman, Izabela Dziatkiewicz, Mateusz Jurek · 2022 · International Journal of Molecular Sciences
2. Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment.
   Francesco Pepe, Pasquale Pisapia, Marialaura Del Basso De, Floriana Conticelli, Umberto Malapelle, Giancarlo Troncone, Juan Carlos Martı́nez · 2020 · PubMed
3. The state of therapy modalities in clinic for biliary tract cancer
   Weixun Chen, Zhengnan Hu, Jia Song, Yu Cheng Wu, Bixiang Zhang, Lei Zhang · 2022 · Frontiers in Bioscience-Landmark
4. Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology
   Evgenii Shumilov, Johanna Flach, Thomas Pabst, Martin Fiedler, Anne Angelillo‐Scherrer, Lorenz H. P. Trümper, Raphael Joncourt, Alexander Kohlmann, Ulrike Bacher · 2018 · Critical Reviews in Oncology/Hematology
5. Association between mutant IDHs and tumorigenesis in gliomas
   Shigeo Ohba, Yuichi Hirose · 2018 · Medical Molecular Morphology
6. Which new agents will be incorporated into frontline therapy in acute myeloid leukemia?
   Richard Maury Stone · 2017 · Best Practice & Research Clinical Haematology
7. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01
   Kenichi Miyamoto, Yosuke Minami · 2019 · International Journal of Clinical Oncology
8. Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma
   Jin Zhu, Yuqi Zhang · 2019 · PeerJ
9. AMPKα1 regulates transcription through H2B O-GlcNAcylation during brown adipogenesis
   Yuxin Cao, Xiangdong Liu, Junxing Zhao, ‬Min Du · 2020 · Acta Biochimica et Biophysica Sinica
10. Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer
    Zhengwei Wu, Yi Fei Lee, Xun Hui Yeo, Ser Yue Loo, Wai Leong Tam · 2021 · Cancers
11. Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma—A Case Report and Systematic Review
    Alexander Yuile, Laveniya Satgunaseelan, Joe Wei, Marina Kastelan, Michael Back, Maggie C Lee, Heng Wei, Michael E. Buckland, Adrian V. Lee, Helen Wheeler · 2022 · Current Issues in Molecular Biology
12. N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic Tool
    Joséphine Briand, Aurélien A. Sérandour, Arulraj Nadaradjane, Gwenola Bougras-Cartron, Dominique Heymann, Benjamin Ory, François M. Vallette, Pierre‐François Cartron · 2020 · Molecular Therapy — Nucleic Acids
13. 3D-QSAR, Scaffold Hopping, Virtual Screening, and Molecular Dynamics Simulations of Pyridin-2-one as mIDH1 Inhibitors
    Yifan Wang, Shunjiang Jia, Fan Wang, Ruizhe Jiang, Xiaodan Yin, Shuo Wang, Ruyi Jin, Hui Guo, Yuping Tang, Yuwei Wang · 2024 · International Journal of Molecular Sciences
14. Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma
    Yu‐Chan Chang, Ming‐Huang Chen, Chun‐Nan Yeh, Michael Hsiao · 2020 · Biomolecules
15. Targeted Therapies for Perihilar Cholangiocarcinoma
    Simon Gray, Ángela Lamarca, Julien Edeline, Heinz‐Josef Klümpen, Richard A Hubner, Mairead Geraldine McNamara, Juan W. Valle · 2022 · Cancers
16. Update for astrocytomas: medical and surgical management considerations
    Matthew Willman, Jonathan Willman, John Figg, Emma Dioso, Sai Sriram, Bankole O. Olowofela, Kevin M. Chacko, Jairo S. Hernandez, Brandon Peter Lucke-Wold · 2023 · Exploration of neuroscience
17. Multi-omics analyses of tumor-associated immune-infiltrating cells with the novel immune checkpoint protein tyrosine phosphatase 1B (PTP1B) in extracellular matrix of brain-lower-grade-glioma (LGG) and uveal-melanoma (UVM)
    Kunhao Bai, Ming-Jiao Zhu, Yiyang Zhang, Xue‐Ping Li, Siliang Chen, Dawei Wang, Yu‐Jun Dai · 2022 · Frontiers in Immunology
18. Isocitrate Dehydrogenase 1 Expression in Canine Gliomas
    AR Fraser, Barbara Bacci, Matthias Le Chevoir, Sam Long · 2018 · Journal of Comparative Pathology
19. Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas?
    Roberta Rudà, Mehdi Touat, Riccardo Soffietti · 2020 · Current Opinion in Neurology
20. A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping
    Baptiste Louveau, Fanélie Jouenne, Pauline Tétu, Aurélie Sadoux, Aurélia Gruber, Eddie Lopes, Julie Delyon, Kévin Serror, Oren Marco, Laetitia Da Meda et al. · 2020 · Targeted Oncology
21. Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials
    Nai‐Jung Chiang, Li‐Tzong Chen, Yan‐Shen Shan, Chun‐Nan Yeh, Ming‐Huang Chen · 2021 · Biomolecules
22. Association of The IDH1 C.395G>A (R132H) Mutation with Histological Type in Malay Brain Tumors
    Abdul Aziz Mohamed Yusoff, Fatin Najwa Zulfakhar, Mohd Dasuki Sul’ain, Zamzuri Idris, Jafri Malin Abdullah · 2016 · Europe PMC (PubMed Central)
23. The impact of molecular profiling on cholangiocarcinoma clinical trials and experimental drugs
    Qurat Ul Ain Riaz Sipra, Rachna T. Shroff · 2020 · Expert Opinion on Investigational Drugs
24. Discovery of novel IDH1-R132C inhibitors through structure-based virtual screening
    Chujiao Hu, Zhirui Zeng, Dan Ma, Zhi-Xin Yin, Shanshan Zhao, Tengxiang Chen, Lei Tang, Shi Zuo · 2022 · Frontiers in Pharmacology
25. Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky
    Jinpeng Liu, Thilakam Murali, Tianxin Yu, Chunming Liu, Theru A. Sivakumaran, Hunter Moseley, Igor B. Zhulin, Heidi L. Weiss, Eric B. Durbin, Sally R. Ellingson et al. · 2018 · Cancer Epidemiology Biomarkers & Prevention
26. Low expression ofFOSL1is associated with favorable prognosis and sensitivity to radiation/pharmaceutical therapy in lower grade glioma
    Jin Zhu, Yapeng Zhao, Yuqi Zhang · 2020 · Neurological Research
27. The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment
    Yuanyuan Liu, Shanwu Yu, Yixiang Chen, Zhìhóng Hú, Lingling Fan, Gaofeng Liang · 2024 · Frontiers in Pharmacology
28. Genomic landscape of biliary tract cancer and corresponding targeted treatment strategies
    Daisaku Yamada, Shogo Kobayashi, Yuichiro Doki, Hidetoshi Eguchi · 2025 · International Journal of Clinical Oncology
29. Nanotechnology in brain cancer treatment: The role of gold nanoparticles as therapeutic enhancers
    Simona Tarantino, Annalisa Bianco, Valeria De Matteis, Edoardo Scarpa, Rosaria Rinaldi · 2025 · Ibrain
30. Structure-Based Drug Design of Novel Triaminotriazine Derivatives as Orally Bioavailable IDH2R140Q Inhibitors with High Selectivity and Reduced hERG Inhibitory Activity for the Treatment of Acute Myeloid Leukemia
    Qingyun Wei, Kun Yao, Jie Yang, Qian Zhou, Pengyu Liu, Jiao Chen, Haipeng Liu, Yisheng Lai, Peng Cao · 2023 · Journal of Medicinal Chemistry
31. Treating Biliary Tract Cancers: New Targets and Therapies
    Joseph K. Ho, Constance Fiocco, Kristen Renee Spencer · 2022 · Drugs
32. Discovery of a novel class of pyridine derivatives that selectively inhibits mutant isocitrate dehydrogenase 2
    Fangying Wang, Zhuoling Li, Tao Zhang, Guoyi Yan, Mingxing Hu, Lifeng Zhao, Yinglan Zhao, Yuanwei Chen · 2017 · Chemical Biology & Drug Design
33. Multifocal Renal Cell Carcinomas With Somatic IDH2 Mutation: Report of a Previously Undescribed Neoplasm
    Maria J. Merino, Christopher J. Ricketts, Vanessa Moreno, Ye Yang, Teresa W.‐M. Fan, Andrew N. Lane, Paul S. Meltzer, Cathy D. Vocke, Daniel R. Crooks, William Marston Linehan · 2020 · The American Journal of Surgical Pathology
34. Mechanism of IDH1-R132H mutation in T cell acute lymphoblastic leukemia mouse model via the Notch1 pathway
    Yonghua Liu, Bingmu Fang, Xiaoning Feng, Yu Han Jiang, Yuxiao Zeng, Jinhong Jiang · 2021 · Tissue and Cell
35. Single-cell profiling of D-2-hydroxyglutarate using surface-immobilized resazurin analogs
    Hanjun Cheng, Zhonghan Li, Zhili Guo, Shiqun Shao, Li Mo, Wei Wei, Min Xue · 2021 · Biosensors and Bioelectronics
36. High-Risk Acute Myeloid Leukemia: A Pediatric Prospective
    Fabiana Cacace, Rossella Iula, Danilo De Novellis, Valeria Caprioli, Maria Rosaria D’Amico, Giuseppina De Simone, Rosanna Cuccurullo, William G. Wierda, Kris Michael Mahadeo, Giuseppe Menna et al. · 2022 · Biomedicines
37. Pyridine ring as an important scaffold in anticancer drugs
    Amr Elagamy, Laila K. Elghoneimy, Reem K. Arafa · 2022 · Elsevier eBooks
38. Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm
    Stéphane de Botton, Christian Récher, Jörge E. Cortes, Antonio Curti, Pierre Fenaux, Pierre Péterlin, Arnaud Pigneux, Karen W L Yee, Andrew H. Wei, Alice S. Mims et al. · 2024 · British Journal of Haematology
39. Knorpeltumoren: Morphologie, Genetik und Basisaspekte der Targettherapie
    Albert Roessner, Maria Anna Smolle, Victor Schoeder, Johannes Haybaeck · 2020 · Der Pathologe
40. Reviewing the IDH1 Mutation‐Mediated Mechanism of Drug Resistance and Revisiting Its Overcoming Strategies
    Yifan Wang, Hailong Bai, Aixin Wang, Jun Zhao, Hui Guo, Yuping Tang, Yuwei Wang, Qinjian Xie · 2025 · Chemical Biology & Drug Design
41. Generation of induced neural stem cells with inducible IDH1R132H for analysis of glioma development and drug testing
    Kamila Rosiak, Dagmara Grot, Piotr Rieske · 2020 · PLoS ONE
42. Decoding the heterogeneous landscape in the development prostate cancer (Review)
    Yenifer Yamile Segura Moreno, María Carolina Sanabria‐Salas, Rodolfo Varela, Jorge Mesa, Martha Lucía Serrano · 2021 · Oncology Letters
43. Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle
    Xiaobo Wang, Lihua Yuan, Bo Lü, Dongjun Lin, Xiaojun Xu · 2023 · Experimental and Therapeutic Medicine
44. TOF-SIMS analysis of an isocitrate dehydrogenase 1 mutation-associated oncometabolite in cancer cells
    Jungdae Park, Hee‐Kyung Na, Hyun Kyong Shon, Hye Young Son, Yong‐Min Huh, Sang‐Won Lee, Tae Geol Lee · 2018 · Biointerphases
45. Mechanisms of Metabolic Reprogramming Regulating Immunosuppression in the Gastric Cancer Tumor Microenvironment
    Wenting Dong, Xuepeng Qian, Honglin Liu, J. A. Huo, Weiming Wang · 2026 · Biomolecules
46. Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma
    Zijian Liu, Jinlan He, Xiaolin Hu · 2022 · Frontiers in Genetics
47. Pharmacophore-based Identification of Potential Mutant Isocitrate Dehydrogenases I/2 Inhibitors: An Explorative Avenue in Cancer Drug Design
    Mahmoud E. S. Soliman, Preantha Poonan, Xylia Q. Peters, Mohamed I. Alahmdi, Nader Elmaghwry Abo-Dya · 2022 · Anti-Cancer Agents in Medicinal Chemistry
48. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy
    Zhirui Zeng, Chujiao Hu, Wanyuan Ruan, Jinjuan Zhang, Shan Lei, Yushi Yang, Pailan Peng, Feng Pan, Tengxiang Chen · 2022 · Frontiers in Immunology
49. Point Mutation Specific Antibodies in B-Cell and T-Cell Lymphomas and Leukemias: Targeting IDH2, KRAS, BRAF and Other Biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2
    Kunwar Singh, Sumanth Gollapudi, Sasha Mittal, Corinn Small, Jyoti Kumar, Robert Shigeo Ohgami · 2021 · Diagnostics
50. High expression of cluster of differentiation 276 indicates poor prognosis in glioma
    Lin‐Chen Li, Min Zhang, Dengna Zhu, Xinjun Wang · 2021 · Clinical Medicine Insights Oncology
51. Oxaloacetate promotes the transition from glycolysis to gluconeogenesis through the Akt-FoxO1 and JNK/c-Jun-FoxO1 axes and inhibits the survival of liver cancer cells
    Zeyu Miao, Yan Liu, Yang Xu, Jiarui Bu, Qing Yang · 2025 · International Immunopharmacology
52. Epigenetic dysregulation in cancers by isocitrate dehydrogenase 2 (IDH2)
    Anuraj Nayarisseri, Srinivas Bandaru, Arshiya Khan, Khushboo Sharma, Anushka Bhrdwaj, Manmeet Pal Kaur, Dipannita Ghosh, Ishita Chopra, Aravind Panicker, Abhishek Kumar et al. · 2024 · Advances in protein chemistry and structural biology
53. Computational study on novel natural compound inhibitor targeting IDH1_R132H
    Baolin Zhou, Fang Yang, Lei Qin, Jun Kuai, Lu Yang, Lanfang Zhang, Peisheng Sun, Guangpeng Li, Xinhui Wang · 2022 · Aging
54. Aquaporin-4 as a New Potential Molecular Biomarker for Prognosis of Low-Grade Glioma: Comprehensive Analysis Based on Online Platforms
    Jin Zhu, Liang Shi, Yibing Su · 2023 · World Neurosurgery
55. Epigenetic therapeutic strategies in pancreatic cancer
    Arturo Orlacchio, Stephen Muzyka, Tamas A. Gonda · 2024 · International review of cytology
56. Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia
    Heba Ahmed Alkhatabi, Haneen Abdulfattah Bin Saddeq, Luay Alyamani, Thoraia Shinawi, Elrashed B. Yasin, Raed F. Alserihi, Raed I. Felimban, Hossam H. Tayeb, Rawan Mimani, Zainab Alalla et al. · 2021 · Genes
57. Machine learning-based identification of exosome-related biomarkers and drugs prediction in nasopharyngeal carcinoma
    Zhengyu Wei, Guoli Wang, Yanghao Hu, Chongchang Zhou, Yuna Zhang, Yi Shen, Yaowen Wang · 2025 · Discover Oncology
58. Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?
    Caterina Alati, Martina Pitea, Maria Caterina Micò, Violetta Marafioti, Maria Bruna Greve, Giulia Pratico, Barbara Loteta, Francesca Cogliandro, Gaetana Porto, Giorgia Policastro et al. · 2024 · Expert Review of Hematology
59. Glioblastoma - Current Evidence
    Amit Agrawal, Daulat Singh Kunwar · 2022 · IntechOpen eBooks
60. CircIDH2 Modulates Porcine Adipogenesis via the miR-193a-5p/RASGRP4 Axis: Implications for ceRNA-Mediated Regulation of Fat Deposition
    Meng Li, Jiayi Chen, Wu Bao, Shuangji Ma, Mingxin Wen, Yuqi Han, Wanfeng Zhang, Yang Yang, Xiaohong Guo, Bugao Li · 2025 · Cells
61. Age-Related Multigene Analysis of Colorectal Cancer Using Next-Generation Sequencing
    Monika A. Kozłowska-Geller, Łukasz Nawacki, Monika Wawszczak-Kasza, Wojciech Lewitowicz, Jacek Bicki, Piotr Lewitowicz · 2025 · Cancers
62. Research on Targeted Therapy for Malignant Tumors of the Biliary Tract
    Yuxin Yang, Hutianyu Zhong, Jingjing Zhang, Peng Wang · 2026 · OncoTargets and Therapy
63. A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an IDH1 Mutation
    Suneel Deepak Kamath, Xiaoqi Lin, Aparna Kalyan · 2018 · The Oncologist
64. Molecular-driven treatment for biliary tract cancer: the promising turning point
    Mara Persano, Marco Puzzoni, Pina Ziranu, Valeria Pusceddu, Eleonora Lai, Andrea Pretta, Clelia Donisi, Giovanna Pinna, Dario Spanu, Erika Cimbro et al. · 2021 · Expert Review of Anticancer Therapy
65. Disorders of Pyruvate Metabolism and the Tricarboxylic Acid Cycle
    M. Brivet, Pauline Gaignard, Manuel Schiff · 2022 · Springer eBooks
66. Current trends in Glioblastoma
    Mihrican Koçak, Özüm Atasoy, Nilsu Çini, Oytun Erbaş · 2021 · Demiroglu Science University Florence Nightingale Journal of Medicine
67. Genetics of nasopharyngeal carcinoma and molecular signaling pathways
    Murtala Bello Abubakar, Siew Hua Gan · 2020 · Elsevier eBooks
68. Selected cytostatic drugs in the treatment of brain glioma – literature review
    Jarosław Bała, Kinga Mitruczuk, Natalia Walo, Paula Wróblewska-Łuczka · 2021 · Medycyna Ogólna i Nauki o Zdrowiu
69. Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases
    Qun Li, Xiaoyan Zhang, Jiao Feng, Dezhi Cheng, Lin Cai, Zhang’an Dai, Shuyu Zhao, Jianmin Li, Jingjing Huang, Fang Yu et al. · 2021 · Frontiers in Oncology
70. Noncanonical (Non-R132H) IDH-Mutated Gliomas
    Tariq Dhiyab Al-Saadi, Roberto Jose Diaz · 2022 · IntechOpen eBooks
71. Fetal de novo heterozygous variant in the isocitrate dehydrogenase 1 gene associated with growth restriction, skeletal, cerebral and vascular anomalies
    Clara Illi, Josefine Theresia Königbauer, Wolfgang Henrich, Laura Fangmann, Charlotte Reinhardt, Sophia Ossmann, Alexander Weichert · 2023 · Prenatal Diagnosis
72. Methylation-Based Characterization of a New IDH2 Mutation in Sinonasal Undifferentiated Carcinoma
    Simon Burgermeister, Simona Stoykova, Fanny S. Krebs, Vincent Zoete, Martial Kamdem Mbefo, Kristof Levente Egervari, Antoine Reinhard, Bettina Bisig, Ekkehard Hewer · 2024 · International Journal of Molecular Sciences
73. Molecular insights into withaferin A: A holistic approach to cancer therapy
    Md. Rezaul Islam, Abdur Rauf, M. Meenakshi Rakesh, Shopnil Akash, Md. Naeem Hossain Fakir, Md. Samiul Islam, Afifa Farzana Naba, Md. Ibrahim Khalil Al-Imran, Taghrid S. Alomar, Hanan A. Ogaly et al. · 2024 · Inorganic Chemistry Communications
74. T1ρ$$ {}_{1\rho } $$ as a Biomarker for IDH1 Mutation Status in a Glioma Mouse Model
    Hannah J. S. Ehler, Saki Sultana, Christa Davis, Kimberly Brewer, James Rioux · 2025 · NMR in Biomedicine
75. A targeted metabolomic method to detect epigenetically relevant metabolites
    Joan Miro-Blanch, Alexandra Junza, Jordi Capellades, Aurélie Balvay, Claire Maudet, Marta Kovatcheva, Silvia Raineri, Sylvie Rabot, Jane Mellor, Manuel Serrano et al. · 2026 · Molecular Metabolism
76. IDH enzyme inhibition in cancer therapy: mechanisms, mutational insights, and effects of IDH inhibitors in glioma, acute myeloid leukemia and chondrosarcoma
    Anthony Josephine, Sekar Ashok Kumar, Sureka Varalakshmi, P. Rajendran · 2026 · 3 Biotech
77. Genome-Wide Selection Sweep between Wild and Local Pigs from Europe for the Investigation of the Hereditary Characteristics of Domestication in Sus Scrofa
    Yiming Gong, Haoyuan Zhang, Ying Yuan, Yongmeng He, Weiyi Zhang, Yanguo Han, Risu Na, Yan Zeng, Jia Luo, Haili Yang et al. · 2022 · Animals
78. Effectiveness and Safety of Different Postoperative Adjuvant Regimens in Patients with Low-Grade Gliomas: A Network Meta-Analysis
    Dongpo Su, Liu Xiaozhuo, Li Xin, Zuo Zhengyao, Wang Qing, Zhen Fameng, Fan Mingming, Qian Han, Mei Li, Tong Chen · 2023 · World Neurosurgery
79. Development of nanoparticles for the Novel anticancer therapeutic agents for Acute Myeloid Leukemia
    Ajay A Bhagwat, Rohit Ramesh Doke, Santosh Dattatraya Ghule, Bipin R. Gandhi · 2023 · International Journal of Pharmaceutical Sciences and Nanotechnology
80. Identification of ALDOB as a novel prognostic biomarker in kidney clear cell renal cell carcinoma
    Xiaoyang Li, You-Yao Xu, Senyan Wu, Xi-xi Zeng, Yan Zhou, Guo-Bin Cheng · 2024 · Heliyon
81. Recent advances and future prospects of adoptive cell-based cancer immunotherapy
    Syed Sahajada Mahafujul Alam, Zarnain Jamil, Arijit Samanta, Safdar Ali, Mehboob Hoque · 2025 · Elsevier eBooks
82. IDH gene mutation in glioma
    Xuejun Li, Leping Liu · 2018 · Cancer translational medicine
83. Ivosidenib in relapsed or refractory acute myeloid leukemia: a profile of its use in the USA
    Emma H. McCafferty, Katherine Ann Lyseng-Williamson · 2019 · Drugs & Therapy Perspectives
84. Early atypical malignant transformation of diffuse low-grade astrocytoma: The importance of genotyping
    Pedro Valente Aguiar, Osvaldo Sousa, Roberto Pestana Silva, Rui Manuel Vaz, Paulo Linhares · 2020 · Neurocirugía
85. A Review of Molecular and Genetic Diagnostics of Myeloid Malignancies with Emphasis on Diagnostics in Bosnia and Herzegovina
    Amina Kurtović-Kozarić, Erna Islamagić, Adna Ašić, Lejla Mehinovic-Cavcic, Larisa Bešić, Hana Sahinbegovic, Hana Komic, Sabira Kurtovic, Lejla Burazerović · 2021 · Acta Medica Academica
86. Ketogenic Diet as Adjunctive Therapy for Malignant Brain Cancer
    Adrienne C. Scheck, Nelofer Syed · 2022 · Oxford University Press eBooks
87. Acute Leukemia Trilineage Blasts Assignment and Epigenetic Mutations
    Amal M, Ines S, B Mbarka, F Chaker, Salem A · 2017 · Journal of Bone Research
88. Does mIDH Inhibitors is a Promising Therapy?
    Nahla A M Hamed · 2017 · Biomedical Journal of Scientific & Technical Research
89. Targeted RNA NextGenSeq profiling in oncology using single molecule molecular inversion probes
    Krissie Lenting, Corina N. A. M. van den Heuvel, Anne van Ewijk, Elizabeth A. Tindall, Wei Ge, Benno Küsters, Maarten te Dorsthorst, Mark ter Laan, Martijn A. Huynen, William P. J. Leenders · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
90. Advances in the Treatment of Adult Relapsed/Refractory Acute Myeloid Leukemia
    明婷 杨 · 2021 · Advances in Clinical Medicine
91. Oncogenic variants guiding treatment in thoracic malignancies
    Pei Meng · 2021
92. Prognostic Factors in Conventional Chondrosarcoma Patients: a SEER Database Analysis
    Peng Fu, Zhenzhen Gao, Ting Sun, Yi Bao, Gang Chen · 2021 · Research Square
93. Prognostic Factors in Patients with Conventional Chondrosarcoma: A SEER Database Analysis
    Peng Fu, Zhenzhen Gao, Ting Sun, Yi Bao, Gang Chen · 2021 · Research Square
94. WITHDRAWN: DNMT inhibitor (decitabine) attenuates tuberculosis-induced spine injury by modulating the expression of microRNA-155 and matrix metalloproteinase-13 via suppressing the hypermethylation of IDH mutant
    Yi Luo, Wenkun Zhang · 2022 · Biochemical and Biophysical Research Communications · Retracted
95. Early atypical malignant transformation of diffuse low-grade astrocytoma: The importance of genotyping
    Pedro Valente Aguiar, Osvaldo Sousa, Roberto Pestana Silva, Rui Manuel Vaz, Paulo Linhares · 2022 · Neurocirugía (English Edition)
96. Acute Leukemias
    Robert Mancini · 2017 · The American Pharmacists Association eBooks
97. Determination of Isocitrate Dehydrogenase (IDH1) mutation in laryngeal squamous cell carcinoma specimens
    Nasrin Shayanfar, Ali Zare‐Mirzaie, Mahsa Mohammadpour, Ensieh Jafari, Amirhosein Mehrtash, Nikoo Emtiazi, Fatemeh Tajik · 2022 · Research Square
98. Minimal residual disease detection of the fusion protein DEK/CAN in t(6;9)(p23;q34) positive acute myeloid Leukemia and identification of target genes and key pathways for leukemogenesis
    Selina Ferrara · 2022
99. Comparison of DNA Sequencing and Multispecific Monoclonal Antibody (Msmab-1) based Immunohistochemical Detection of IDH1/2 Mutation in Acute Myeloid Leukemia Cases.
    Akanksha Agarwal, Mili Jain, Rashmi Kushwaha, Shikha Tewari, Seema Nayak, Nishant Verma, Anil Kumar Tripathi, Ashutosh Kumar · 2023 · International Journal of Medical Science and Diagnosis Research
100. Molecular Subtypes of Ovarian Cancer Based on Lipid Metabolism and Glycolysis Reveals Potential Therapeutic Targets
     Xiangyu Wang, Wenli Xie, Di Zhao, Ming Liu, Wenqing Li, Ru Wang, Lianbao Cao, Hao Yu · 2023 · Frontiers in Bioscience-Landmark